In the early days of the COVID-19 pandemic, tens of thousands of young volunteers offered to risk their health by letting scientists intentionally infect them with the pandemic coronavirus, hoping to speed the hunt for a vaccine or treatment. Several research groups announced plans to run these so-called human challenge trials, even as some scientists questioned whether they could be conducted ethically. Now, with recent news that conventional human trials have produced several promising vaccines, scientists are debating whether planned challenge trials are still needed. In the United States, one nascent effort is on hold. In the United Kingdom, however, researchers say they are moving ahead. To read the full story.
- Princeton Students Awarded Community-Engaged Population Health Microinternships
- Join NJ ACTS Biostatistics, Epidemiology, Research Design for the March 7th Workshop Series
- Case Western Reserve University CTSA hosts Women’s Health Equity Un-Meeting on Wednesday, March 13, 2024
- Road to Commercialization Symposium Series on March 26th
- Rutgers Climate and Energy Institute Workshop on March 21st – Register Today